J&J debt trades lower after pause of one-shot COVID-19 vaccine

Johnson & Johnson's corporate bonds are trading lower across the board Tuesday, after two leading U.S. health agencies recommended a pause on its one-shot COVID-19 vaccine after six vaccinated women developed blood clotting.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.